Hospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

2006

  1. Comorbidity as a factor limiting HAART

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. SUPPL.2, pp. 1-12